KLK3 and prostate cancer: In this subset, men with low free testosterone had a reduced risk of prostate cancer (OR = 0.74; 95% CI = 0.64–0.85); further adjustment for PSA attenuated the association to the null (OR = 0.92; 95% CI 0.76–1.12).